Dade Behring Test Gets FDA Approval

Dade Behring, a maker of blood-testing kits, has received FDA approval to use its NT-proBNP test on the company's Stratus CS Acute Care Diagnostics System.

Dade Behring said the test has been cleared to aid in the diagnosis of heart failure, including assessment of heart failure severity in patients diagnosed with congestive heart failure and risk stratification of patients with acute coronary syndrome and heart failure.

The test will begin shipping later this month.